ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Racial Differences In Survival Increase According To Stage

August 31, 2007

In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named

June 15, 1990

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

May 18, 2012

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012